Cara Therapeutics Inc (CARA)
0.7782
+0.01
(+0.78%)
USD |
NASDAQ |
May 03, 16:00
0.7787
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Accounts Receivable (Quarterly): 2.765M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.765M |
September 30, 2023 | 3.351M |
June 30, 2023 | 10.12M |
March 31, 2023 | 6.066M |
December 31, 2022 | 3.26M |
Date | Value |
---|---|
September 30, 2022 | 9.623M |
June 30, 2022 | 8.003M |
March 31, 2022 | 2.496M |
December 31, 2021 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
10.12M
Maximum
Jun 2023
5.076M
Average
3.351M
Median
Sep 2023
Accounts Receivable (Quarterly) Benchmarks
Nektar Therapeutics | 1.205M |
Stereotaxis Inc | 3.822M |
Cerus Corp | 35.50M |
Avid Bioservices Inc | 18.54M |
Rigel Pharmaceuticals Inc | 30.55M |